Court blocks US gov's 340B Rebate Model Pilot Program, citing failure to meet admin law reqs. Hospital groups argued for ...

The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the ...

In Washington, D.C., lawmakers are engaged in marathon talks about how to reduce health care costs. There haven’t been any ...

A U.S. appeals court panel has refused to allow the Trump administration to proceed with a pilot initiative tied to a ...

Ten medications accounted for nearly one-third of 340B program-covered outpatient drugs in 2024, according to a Dec. 11 report. The Health Resources and Services Administration, an HHS agency, ...

Ahead of HHS’ planned 340B rebate pilot program, several healthcare organizations urged congressional leaders to cancel the pilot they say would threaten care access for low-income and rural patients.

As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it. The 340B Drug Pricing ...

A federal judge in Maine has put the brakes on a pilot program that would have enabled biopharma companies to offer rebates instead of discounts as part of the 340B program beginning Jan. 1, 2026.

"Such a change would inflict hundreds of millions of dollars’ worth of annual costs on hospitals and other covered entities." ...

A federal judge issued a preliminary injunction against a new government pilot set to significantly shift how certain ...

The First Circuit upheld a district court’s pause of the controversial pilot on Wednesday. It’s a setback for the Trump ...